Navigation Links
Amylin Pharmaceuticals to Present at the 2010 Citi Investment Research Global Healthcare Conference
Date:5/19/2010

SAN DIEGO, May 19, 2010 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) will be presenting at the Citi Investment Research Global Healthcare Conference in New York on Wednesday, May 26, 2010 at 3:00 p.m. ET / 12:00 p.m. PT. Alex Casdin, vice president, finance at Amylin Pharmaceuticals, will provide a corporate overview.

The presentation will be webcast live through the "Investors" section of Amylin's corporate Web site at www.amylin.com, and a recording will be made available on the Web site following the event. To access the live webcast, please log on to Amylin's site approximately fifteen minutes prior to the presentation to register and download any necessary audio software.

About Amylin Pharmaceuticals

Amylin Pharmaceuticals is a biopharmaceutical company dedicated to improving lives of patients through the discovery, development and commercialization of innovative medicines. Amylin has developed and gained approval for two first-in-class medicines for diabetes, SYMLIN® (pramlintide acetate) injection and BYETTA® (exenatide) injection. Amylin's research and development activities leverage the Company's expertise in metabolism to develop potential therapies to treat diabetes and obesity. Amylin is headquartered in San Diego, California. Further
'/>"/>

SOURCE Amylin Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Amylin Pharmaceuticals to Present at the Deutsche Bank 35th Annual Healthcare Conference
2. Amylin Pharmaceuticals to Webcast Third Quarter Results
3. Amylin and Lilly to Present More than 20 Studies for Exenatide at EASD 2009
4. Amylin Pharmaceuticals to Present at Morgan Stanley Global Healthcare Unplugged Conference
5. Amylin Pharmaceuticals Board of Directors Elects Paulo F. Costa Chairman of the Board
6. Amylin Pharmaceuticals to Webcast Second Quarter Results
7. Amylin Pharmaceuticals Announces Positive Results from Dose-Ranging Clinical Study of Pramlintide/Metreleptin Combination Treatment for Obesity
8. Amylin Pharmaceuticals to Present at Piper Jaffray Europe Conference
9. Amylin Pharmaceuticals to Present at Goldman Sachs Annual Global Health Care Conference
10. Amylin Announces Preliminary Tabulation of Annual Meeting Results
11. Amylin Responds to Eastbourne Letter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... MA, San Antonio, TX (PRWEB) August 29, 2014 ... ISO 9001:2008 and ISO 13485:2003 certified, GAMP® 5 ... has been awarded an international Phase II clinical ... with non-Hodgkin’s lymphoma. , Throughout this trial, Intrinsic ... including, but not limited to, protocol and charter ...
(Date:8/28/2014)... LAFAYETTE, Ind. A new research platform ... properties of tiny structures undergoing stress and ... to improve designs for microelectronics and batteries., ... reveals information about how heating and the ... mechanical properties. Researchers have discussed the merits ...
(Date:8/28/2014)... --  SunTrust Robinson Humphrey (STRH) today announced ... equity research team in biotechnology and oilfield services.  ... research demonstrates our commitment to providing our valued ... investment decision making," said Biff Woodruff , ... make significant investments in differentiated content at a ...
(Date:8/28/2014)... Vt. (PRWEB) August 28, 2014 ... testing around the world is available from Strategic ... diagnostics companies. “ Industrial Microbiology Market Review, Fourth ... Industrial Market ” (IMMR—4) tracks and compares microbiology ... in North America, Europe and Asia, and forecasts ...
Breaking Biology Technology:Intrinsic Imaging Awarded Phase II Clinical Trial to Assess New Treatment for Non-Hodgkin’s Lymphoma 2New analytical technology reveals 'nanomechanical' surface traits 2New analytical technology reveals 'nanomechanical' surface traits 3SunTrust Robinson Humphrey Expands Equity Research in Healthcare and Energy 2SunTrust Robinson Humphrey Expands Equity Research in Healthcare and Energy 32 Billion Industrial Microbiology Tests Conducted for Product Quality and Safety Worldwide 22 Billion Industrial Microbiology Tests Conducted for Product Quality and Safety Worldwide 3
... , ,We have all seen or heard the security ... his or her laptop and ask, "How can we make ... and physical cabling. The expert agrees with all of the ... be bypassed." Finally, he or she unplugs all of ...
... partnering up for two years, the Wisconsin Life ... Biotech & Medical Device Conference have decided to ... audiences and themes, these autumn conferences are now being ... Venture Investors LCC and member of both ...
... biotech entrepreneurs , ,MADISON If you stand on ... documents hanging in the lobby of UW Madison's new $35.6 ... issued to Hector Floyd DeLuca and colleagues back ... vitamin D3. Those patents are responsible for the money that ...
Cached Biology Technology:How to increase your online security 2How to increase your online security 3Life science VC and biotech confabs to fly solo this fall 2DeLuca speaks out on entrepreneurialism, tech transfer, and WARF 2DeLuca speaks out on entrepreneurialism, tech transfer, and WARF 3
(Date:9/1/2014)... Boston, MA ─ Dietary quality in the U.S. has ... reduced trans fat intakebut overall dietary quality remains poor ... groups, according to a new study from Harvard School ... most direct evidence to date that the extensive efforts ... quality are having some payoff, but it also indicates ...
(Date:9/1/2014)... the alteration of a single nucleotidethe basic building block of DNAcould ... disability. The study appears in The Journal of Cell ... by a defect in a gene on the X chromosome called ... 230 women and 1 in 360 men carry a so-called premutation, ... the FMR1 gene is slightly longer than normal. These ...
(Date:8/31/2014)... test provides a fast and accurate tool to ... shows. The newly developed test (TAM-TB assay) is ... tuberculosis in children. The test features excellent specificity, ... with speed of a blood test. The promising ... of tuberculosis in children, particularly in tuberculosis-endemic regions. ...
Breaking Biology News(10 mins):Quality of US diet shows modest improvement, but overall remains poor 2Quality of US diet shows modest improvement, but overall remains poor 3A nucleotide change could initiate fragile X syndrome 2New tuberculosis blood test in children is reliable and highly specific 2
... DURHAM, N.C. -- Since Congress lifted a moratorium on offshore ... of how best to regulate U.S. ocean waters to allow ... fisheries and marine animal habitats. A ... by a team of Duke University experts, argues that establishing ...
... LA JOLLA, Calif., April 9, 2009Scientists at Burnham Institute ... San Diego (UC San Diego) School of Medicine have ... protected from the immune system when encapsulated in polytetrafluorethylene ... treating Type 1 diabetes, was published online on April ...
... in the Department of Physiology and Cell Biology have discovered insight ... have significant implications for male infertility and contraception. ... important discovery has been published in Nature Genetics , one ... upon the impact factor. ...
Cached Biology News:Public trust doctrine could aid management of US oceans 2Public trust doctrine could aid management of US oceans 3Device protects transplanted pancreatic cells from the immune system 2Small RNAs can play critical roles in male infertility/contraception 2
Includes a choice of any 3 EasySep mouse selection kits and EasySep magnet...
... These 1.5L PYREX trypsinizing ... homogenous tissue samples into cell ... proteins. Heavy beaded neck accepts ... enhance vigorous agitation. • Height ...
... For the efficient enrichment of functional ... or cell culture. The isolated ER ... and metabolic pathway analysis. Metabolic abnornalities ... in children, cystic fibrosis and many ...
Plasmid expressing PLAP reporter gene....
Biology Products: